Authors
Loading...
Randomized trial evaluates miR-191-3p's role in airway inflammation among asthma patients, suggesting therapeutic potential.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: